Ligand Pharma (LGND) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $291.77 -0.96%
Financial Fact:
General and administrative: 6.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 6.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $21.6 million versus the consensus estimate of $23.13 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc eyes US banking license as next business step
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
